Citation: | LOU Fang-fang, SUN Jian-chao, HUANG Jian.et al, . Effects of 1,25(OH)2D3 and its combination with LY294002 on proliferation and invasion of human hepatocellular carcinoma HepG2 cells[J]. Chinese Journal of Public Health, 2016, 32(1): 81-84. doi: 10.11847/zgggws2016-32-01-24 |
[1] |
Siegel R,Ma J,Zou Z,et al.Global cancer statistics[J].CA Cancer J Clin,2014,64(1):9-29.
|
[2] |
Chan SL,Mok T,Ma BB.Management of hepatocellular carcinoma:beyond sorafenib[J].Curr O ncol Rep,2012,3(14):257-266.
|
[3] |
王明月,杨光,王刚,等.中国2004-2008年恶性肿瘤城乡死亡率分析[J].中国公共卫生,2013,29(7):1038-1040.
|
[4] |
孔菲菲,厉小梅.1,25-二羟维生素D3的免疫调节作用新进展[J].细胞与分子免疫学杂志,2013,29(05):553-555.
|
[5] |
Handono K,Sidarta YO,Pradana BA,et al.Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus[J].Acta Med Indones,2014,46(3):189-198.
|
[6] |
Chiuso-Minicucci F,Ishikawa LL,Mimura LA,et al.Treatment with vitamin D/MOG association suppresses experimental autoimmune encephalomyelitis[J].PLoS One,2015,10(5):1-14.
|
[7] |
Van Belle TL,Vanherwegen AS,Feyaerts D,et al.1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type1 diabetes patients[J].PLoS One,2014,9(10):e109194.
|
[8] |
Reddy KK.Reply to Glossmann:vitamin D compounds and oral supplementation methods[J].J Invest Dermatol,2013,133(11):589-592.
|
[9] |
Takahashi H,Hatta Y,Iriyama N,et al.Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3[J].PLoS One,2014,9(11):e113722.
|
[10] |
Zhang Z,Zhang H,Hu Z,et al.Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells[J].Oncol Lett,2014,8(3):1348-1354.
|
[11] |
Jiang J,Zhang Y,Guo Y,et al.MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation[J].Oncotarget,2015,6(8):6359-6372.
|
[12] |
Gao R,Cai C,Gan J,et al.miR-1236 down-regulates alpha-fetoprotein,thus causing PTEN accumulation,which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells[J].Oncotarget,2015,6(8):6014-6028.
|
[13] |
Joyce JA,Pollard JW.Microenviromental regulation of metastasis[J].Nat Rev Cancer,2009,9(4):239-252.
|
[14] |
Sengupta B,ASiddiqi S.Hepatocellular carcinoma:important bio-markers and their significance in molecular diagnostics and therapy[J].Curr Med Chem,2012,19(22):3722-3729.
|
[15] |
Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancel[J].Science,1997,275(5308):1943-1947.
|
[16] |
Sharrard RM,Norman JM.Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines[J].Cell Signal,2007,19(1):129-138.
|
[17] |
Chen J,Wang Q,Fu X,et al.Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma:association with MMP-9[J].Hepatol Res,2009,39(2):177-186.
|
[18] |
胡明英,王晓莉,毕学辉,等.RNA干扰沉默AKT基因对卵巢癌SKOV3细胞增殖与凋亡影响研究[J].中华肿瘤防治杂志,2013,20(24):1869-1873.
|
[19] |
Shan RF,Zhou YF,Peng AF,et al.Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro[J].Exp Ther Med,2014,8(3):1005-1009.
|